Fabiola Solorzano-Ibarra

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursNanotoxicology, health and safetyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
Natural Killer Cell Phenotype and Function as a Predictive Factor for Treatment Response to Neoadjuvant Therapy in Breast Cancer Patients.

Cinthya Yareli Anguiano Serrato, Fabiola Solorzano-Ibarra, Ignacio Mariscal-Ramirez

|Feb 13, 2026
Prostate Cancer: Dissecting Novel Immunosuppressive Mechanisms Through Context-Specific Transcriptomic Programs and MDSC Cells.

Pedro Reyes Martinez, Erick Sierra Diaz, Fabiola Solorzano Ibarra

|Nov 27, 2025
T Cell Exhaustion in the Cervical Cancer Tumor Microenvironment: PD-1 Overexpression and Co-Expression with TIGIT, Tim-3, LAG-3, and NKG2A.

Nadia Tatiana García-Barrientos, Fabiola Solorzano-Ibarra, Ksenia Klimov-Kravtchenko

|Aug 27, 2025
Pentoxifylline Enhances the Effects of Doxorubicin and Bleomycin on Apoptosis, Caspase Activity, and Cell Cycle While Reducing Proliferation and Senescence in Hodgkin's Disease Cell Line.

Jesús A Gutiérrez-Ortiz, Oscar Gonzalez-Ramella, Fabiola Solorzano-Ibarra

|Sep 28, 2024
New Advances in the Study of CMTM6, a Focus on Its Novel Non-Canonical Cellular Locations, and Functions beyond Its Role as a PD-L1 Stabilizer.

Pedro Ivan Urciaga-Gutierrez, Ramon Antonio Franco-Topete, Blanca Estela Bastidas-Ramirez

|Aug 29, 2024
Uncovering the Expression Pattern of the Costimulatory Receptors ICOS, 4-1BB, and OX-40 in Exhausted Peripheral and Tumor-Infiltrating Natural Killer Cells from Patients with Cervical Cancer.

Jose Manuel Rojas-Diaz, Fabiola Solorzano-Ibarra, Nadia Tatiana Garcia-Barrientos

Pageof 2